News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Neuropharm Group plc Shares Plunge as Lead Drug Misses



2/18/2009 7:44:18 AM

LONDON, Feb 18 (Reuters) - British autism specialist Neuropharm said on Wednesday that its lead drug has missed a key goal in large-scale trials, sending shares plunging 66 percent.

Read at Reuters


comments powered by Disqus
Reuters
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES